| Ogechi Ann Ohia, AGACNP-BC | |
|
12361 W Bola Dr Ste 109, Surprise, AZ 85378-9021 | |
| (623) 227-1000 | |
| Not Available |
| Full Name | Ogechi Ann Ohia |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Acute Care |
| Location | 12361 W Bola Dr Ste 109, Surprise, Arizona |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063013605 | NPI | - | NPPES |
| 32195 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LA2100X | Nurse Practitioner - Acute Care | AP143724 (Texas) | Primary |
| 363L00000X | Nurse Practitioner | AP143724 (Texas) | Secondary |
| Entity Name | Christus Trinity Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285684225 PECOS PAC ID: 3072426741 Enrollment ID: O20031204001091 |
News Archive
Flexuspine, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted conditional approval to begin the initial phase of the Investigational Device Exemption (IDE) for a feasibility study of its FSU device. This is the first approved clinical study for a Total Spine Arthroplasty system in the U.S.
Those who were taught how to translate the information consumed more. Researchers believe the same is true for other beneficial nutrients.
Tiny vesicles containing protective substances which they transmit to nerve cells apparently play an important role in the functioning of neurons. As cell biologists at Johannes Gutenberg University Mainz (JGU) have discovered, nerve cells can enlist the aid of mini-vesicles of neighboring glial cells to defend themselves against stress and other potentially detrimental factors.
Cytheris SA, a clinical-stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced the publication of a case study report based on successful treatment of Progressive Multifocal Leukoencephalopathy (PML) with combination therapy consisting of two investigational agents, Cytheris' recombinant human interleukin-7 (CYT107) and CMX001, an investigational, oral broad-spectrum antiviral drug (Chimerix, Research Triangle Park, NC) in the Journal of Antimicrobial Chemotherapy.
The Colorado Rural Health Center has launched the Health Awareness for Rural Communities (HARC) Data Bank, which enhances access to streamlined data sharing and collaboration for rural healthcare providers, communities and other interested stakeholders.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ogechi Ann Ohia, AGACNP-BC 2626 Deerwood Heights Ln, Manvel, TX 77578-2058 Ph: (414) 659-3333 | Ogechi Ann Ohia, AGACNP-BC 12361 W Bola Dr Ste 109, Surprise, AZ 85378-9021 Ph: (623) 227-1000 |
News Archive
Flexuspine, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted conditional approval to begin the initial phase of the Investigational Device Exemption (IDE) for a feasibility study of its FSU device. This is the first approved clinical study for a Total Spine Arthroplasty system in the U.S.
Those who were taught how to translate the information consumed more. Researchers believe the same is true for other beneficial nutrients.
Tiny vesicles containing protective substances which they transmit to nerve cells apparently play an important role in the functioning of neurons. As cell biologists at Johannes Gutenberg University Mainz (JGU) have discovered, nerve cells can enlist the aid of mini-vesicles of neighboring glial cells to defend themselves against stress and other potentially detrimental factors.
Cytheris SA, a clinical-stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced the publication of a case study report based on successful treatment of Progressive Multifocal Leukoencephalopathy (PML) with combination therapy consisting of two investigational agents, Cytheris' recombinant human interleukin-7 (CYT107) and CMX001, an investigational, oral broad-spectrum antiviral drug (Chimerix, Research Triangle Park, NC) in the Journal of Antimicrobial Chemotherapy.
The Colorado Rural Health Center has launched the Health Awareness for Rural Communities (HARC) Data Bank, which enhances access to streamlined data sharing and collaboration for rural healthcare providers, communities and other interested stakeholders.
› Verified 3 days ago
Celine Tubillara Villariz, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 14973 W Bell Rd Ste 100, Surprise, AZ 85374 Phone: 623-934-1245 Fax: 623-934-3598 | |
Robert Wolfe, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 18761 N Reems Rd Ste 400, Surprise, AZ 85374 Phone: 623-583-9180 | |
Herlinda C Castro, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 15351 W Bell Rd, Surprise, AZ 85374 Phone: 877-809-5092 | |
Zofia Wilk, FNP-BC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 13945 W Grand Ave Ste 105, Surprise, AZ 85374 Phone: 623-546-0007 | |
Paige Leykam, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 14780 W Mountain View Blvd Ste 211, Surprise, AZ 85374 Phone: 480-428-7678 Fax: 480-569-2708 | |
Catherine Lisondra Krings, MSN,FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 13945 W Grand Ave Ste A-105, Surprise, AZ 85374 Phone: 623-546-0007 Fax: 623-584-6915 |